HK1198031A1 - 有用於治療濫用藥物及酒精的 衍生物 - Google Patents

有用於治療濫用藥物及酒精的 衍生物

Info

Publication number
HK1198031A1
HK1198031A1 HK14111535.3A HK14111535A HK1198031A1 HK 1198031 A1 HK1198031 A1 HK 1198031A1 HK 14111535 A HK14111535 A HK 14111535A HK 1198031 A1 HK1198031 A1 HK 1198031A1
Authority
HK
Hong Kong
Prior art keywords
thevinol
orvinol
drug
treatment
derivatives useful
Prior art date
Application number
HK14111535.3A
Other languages
English (en)
Inventor
John Lewis
Stephen Husbands
Original Assignee
Univ Bath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bath filed Critical Univ Bath
Publication of HK1198031A1 publication Critical patent/HK1198031A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK14111535.3A 2011-07-08 2014-11-14 有用於治療濫用藥物及酒精的 衍生物 HK1198031A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1111775.1A GB201111775D0 (en) 2011-07-08 2011-07-08 Compounds and uses thereof
PCT/GB2012/051575 WO2013007986A1 (en) 2011-07-08 2012-07-05 Orvinol and thevinol derivatives useful in the treatment of drug and alcohol abuse

Publications (1)

Publication Number Publication Date
HK1198031A1 true HK1198031A1 (zh) 2015-03-06

Family

ID=44544490

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14111535.3A HK1198031A1 (zh) 2011-07-08 2014-11-14 有用於治療濫用藥物及酒精的 衍生物

Country Status (16)

Country Link
US (5) US9051334B2 (zh)
EP (1) EP2729469B1 (zh)
JP (2) JP6117780B2 (zh)
CA (1) CA2841169C (zh)
CY (1) CY1117674T1 (zh)
DK (1) DK2729469T3 (zh)
ES (1) ES2572508T3 (zh)
GB (1) GB201111775D0 (zh)
HK (1) HK1198031A1 (zh)
HR (1) HRP20160389T1 (zh)
HU (1) HUE028785T2 (zh)
PL (1) PL2729469T3 (zh)
RS (1) RS54830B1 (zh)
SI (1) SI2729469T1 (zh)
SM (1) SMT201600154B (zh)
WO (1) WO2013007986A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111775D0 (en) 2011-07-08 2011-08-24 Univ Bath Compounds and uses thereof
HUE040284T2 (hu) 2011-10-03 2019-02-28 Johnson Matthey Plc Eljárás buprenorfin elõállítására
EP3087078B1 (en) * 2013-12-26 2019-05-15 Purdue Pharma LP 7-beta-alkyl analogs of orvinols
TW201607923A (zh) 2014-07-15 2016-03-01 歌林達有限公司 被取代之氮螺環（４．５）癸烷衍生物
GB201716830D0 (en) 2017-10-13 2017-11-29 Cambrex Charles City Inc New Process
CN110117288A (zh) * 2018-02-07 2019-08-13 复旦大学 7β-甲基-奈培酮衍生物及其制备方法和用途
CN114195798B (zh) * 2021-12-31 2023-07-28 复旦大学 7α-甲基稠环吗啡类衍生物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB937214A (en) 1961-06-02 1963-09-18 J F Macfarlan & Company Ltd Oripavine derivatives
GB1136214A (en) 1965-06-15 1968-12-11 Reckitt & Sons Ltd Thebaine and oripavine derivatives
GB925723A (en) 1960-09-05 1963-05-08 J F Macfarlan & Company Ltd Novel thebaine derivatives
US3474101A (en) 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
GB902659A (en) 1961-02-02 1962-08-09 J F Macfarlan & Company Ltd A process for the production of a derivative of thebaine
NL289751A (zh) 1962-03-02
DE1493696A1 (de) 1965-02-17 1969-12-18 Hoechst Ag Verfahren zur Herstellung klarfluessiger,leicht mit Wasser verduennbarer Fettsaeurekondensationsprodukte
WO2004078178A1 (en) 2003-03-03 2004-09-16 Markus Heilig Buprenorphine compounds for treatment of alcohol dependence and excessive alcohol use
GB201111775D0 (en) * 2011-07-08 2011-08-24 Univ Bath Compounds and uses thereof

Also Published As

Publication number Publication date
US20150202200A1 (en) 2015-07-23
SI2729469T1 (sl) 2016-07-29
US9051334B2 (en) 2015-06-09
EP2729469B1 (en) 2016-03-30
JP2015172089A (ja) 2015-10-01
US20170044173A1 (en) 2017-02-16
US9890170B2 (en) 2018-02-13
HUE028785T2 (en) 2017-01-30
US20140213603A1 (en) 2014-07-31
CA2841169C (en) 2019-08-27
EP2729469A1 (en) 2014-05-14
RS54830B1 (sr) 2016-10-31
JP6117780B2 (ja) 2017-04-19
US9259422B2 (en) 2016-02-16
SMT201600154B (it) 2016-08-31
CA2841169A1 (en) 2013-01-17
DK2729469T3 (en) 2016-07-18
HRP20160389T1 (hr) 2016-07-01
US20180030062A1 (en) 2018-02-01
US9480684B2 (en) 2016-11-01
ES2572508T3 (es) 2016-05-31
PL2729469T3 (pl) 2016-09-30
WO2013007986A1 (en) 2013-01-17
JP6117862B2 (ja) 2017-04-19
GB201111775D0 (en) 2011-08-24
JP2014522854A (ja) 2014-09-08
US10030031B2 (en) 2018-07-24
US20160136151A1 (en) 2016-05-19
CY1117674T1 (el) 2017-05-17

Similar Documents

Publication Publication Date Title
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
IL232256A0 (en) Purine derivatives and their use in the treatment of diseases
HK1207065A1 (zh) 氮雜環衍生物及其在藥物中的應用
IL228923A (en) Heterocyclic compounds in the ovaries and their use in treatment
PL2898885T3 (pl) Pochodne pirolopirymidynowe do zastosowania w leczeniu zakażeń wirusowych
HK1197159A1 (zh) 吡非尼酮和選定患者的抗纖維化治療
HK1199712A1 (zh) Β- -甲基- -亞甲基- -氧代- -孕甾- -烯- β-碳內酯、包含所述化合物的藥物製劑及其在治療子宮內膜異位症中的用途
HK1198031A1 (zh) 有用於治療濫用藥物及酒精的 衍生物
GB201120993D0 (en) Novel compounds and their use in therapy
IL230957B (en) Pharmacy methods and preparations for the treatment of an eye disease in a patient
IL229381B (en) Brilacitidine and its results for use in the treatment of mucositis
EP2718283A4 (en) INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
EP2872208A4 (en) SLEEPING SUPPORTING ARTICLE AND METHOD OF APPLICATION THEREFOR
HK1212255A1 (zh) 青蒿素和其衍生物用於治療腎病
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
EP2817304A4 (en) NOVEL COMPOUNDS AND THEIR THERAPEUTIC USE
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
HK1203430A1 (zh) 可用於治療炎症和癌症的二芳基磺酰胺
EP2744786A4 (en) SUBSTITUTED 2-IMIDAZOLIDINONE AND 2-IMIDAZOLONE AND THEIR USE IN THE TREATMENT OF CANCER
ZA201503266B (en) Pyidone derivatives and uses thereof in the treatment of tuberculosis
EP2783685A4 (en) USE OF LEVO-OXIRACETAM AND OXIRACETAM IN THE MANUFACTURE OF MEDICAMENTS FOR PROPHYLAXIS OR TREATMENT OF KOMA
GB201109846D0 (en) Artemisinin and its derivatives for use in medicine
ZA201404052B (en) 18-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17b-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in treatment of endometriosis
GB201112578D0 (en) Pharmaceutical preparation and use
GB201109845D0 (en) Artemisinin and its derivatives for use in the treatment of trauma haemorrhage and associated conditions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210705